XYLANASE-MUTANTE

Patent europeic · EP3670654 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3670654
Numer da la dumonda
EP18845993
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
19-04-2018
Publitgà
24-06-2020
Concedì
01-10-2025
La protecziun finescha il pli tard
18-04-2038
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
C12N 9/42 (2006.01)
C12N 15/56 (2006.01)
C12N 15/81 (2006.01)
C12N 1/19 (2006.01)
C12R 1/84 (2006.01)
Prioritad
CN 201710712383 18.08.2017
Dumonda PCT
PCT/CN2018/083635 19.04.2018
Publicaziun PCT
WO2019/033775 21.02.2019
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 12-08-2026

    Midada

    Published in Swissreg on 12.08.2026

  2. 01-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.10.2025

Partidas

Possessur

Qingdao Vland Biotech Group Co. Ltd.

Room 12A07 Shandong Expressway Mansion No. 29 Miaoling Road Laoshan District, Qingdao, Shandong 266061, CN

Inventur

WU, Xiuxiu

Shandong 266101, CN

SHAO, Chao

Shandong 266101, CN

HUANG, Yijun

Shandong 266101, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.